...
首页> 外文期刊>Clinical and Experimental Metastasis >Inhibitory effect of non-anticoagulant heparin (S-NACH) on pancreatic cancer cell adhesion and metastasis in human umbilical cord vessel segment and in mouse model
【24h】

Inhibitory effect of non-anticoagulant heparin (S-NACH) on pancreatic cancer cell adhesion and metastasis in human umbilical cord vessel segment and in mouse model

机译:非抗凝肝素(S-NACH)对人脐带血管段和小鼠模型中胰腺癌细胞黏附和转移的抑制作用

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Metastasis is the most devastating aspect of cancer and it is the main cause of morbidity and mortality in cancer patients. Tumor cell adhesion to the vascular endothelial cell lining is an important step in metastatic progression and is prompted by platelets. Mucin 1 is over-expressed and aberrantly glycosylated in more than 60% of pancreatic ductal adeno-carcinomas, which mediate adhesion of pancreatic cancer cells to platelets via P-selectin. The anticoagulant low molecular weight heparins (LMWHs), which are commonly used in venous Thromboprophylaxis and treatment, appear to have an effect on cancer survival. The aim of this study is to investigate the effect of platelets on human pancreatic cancer MPanc96 cell adhesion to the endothelial cell vessel wall, and to examine the effect of heparin derivatives on MPanc96 adhesion using a novel, in vitro model of human umbilical cord vein. The modified heparin S-NACH (sulfated non-anticoagulant heparin), which is devoid of antithrombin (AT) binding and devoid of inhibition of systemic AT-dependent coagulation factors such as factor Xa and IIa, and the LMWH tinzaparin both potently reduced adhesion and invasion of fluorescence-labeled MPanc96 cancer cells to the endothelial layer of umbilical cord vein in a dose-dependent manner. S-NACH effectively inhibited P-selectin mediated MPanc96 cell adhesion, and inhibited cell adhesion and invasion similar to tinzaparin, indicating that systemic anticoagulation is not a necessary component for heparin attenuation of cancer cell adhesion, invasion, and metastasis. Also, S-NACH and tinzaparin versus unfractionated heparin, heparin derivatives enoxaparin, deltaparin, fraxiparin, and fondaparinux were evaluated for their effect on platelet-cancer cell adhesion. An in vivo anti-metastatic S-NACH-treated nude mouse model of MPanc96 pancreatic cancer cell metastasis demonstrated potent anti-metastasis efficacy as evidenced by IVIS imaging and histological staining.
机译:转移是癌症最具破坏性的方面,并且是癌症患者发病率和死亡率的主要原因。肿瘤细胞对血管内皮细胞内壁的粘附是转移进程中的重要步骤,并由血小板引起。在超过60%的胰腺导管腺癌中,粘蛋白1过表达并且糖基化,它们通过P-选择蛋白介导胰腺癌细胞与血小板的粘附。通常用于静脉血栓预防和治疗的抗凝低分子量肝素(LMWHs)似乎对癌症存活率有影响。这项研究的目的是研究血小板对人胰腺癌MPanc96细胞粘附于内皮细胞壁的影响,并使用新型体外人脐带静脉模型检查肝素衍生物对MPanc96粘附的影响。修饰的肝素S-NACH(硫酸化非抗凝肝素)没有抗凝血酶(AT)结合,也没有抑制全身性AT依赖的凝血因子(例如Xa和IIa因子),而LMWH替扎肝素均能有效降低粘附力和荧光标记的MPanc96癌细胞以剂量依赖的方式侵入脐静脉的内皮层。 S-NACH与丁扎肝素相似,有效抑制P-选择素介导的MPanc96细胞黏附,并抑制细胞黏附和侵袭,表明系统性抗凝不是肝素减弱癌细胞黏附,侵袭和转移的必要成分。此外,还评估了S-NACH和替扎肝素与普通肝素,肝素衍生物依诺肝素,deltaparin,fraxiparin和fondaparinux对血小板-癌细胞粘附的影响。经IVIS成像和组织学染色证实,经MPa-96胰腺癌细胞转移的体内抗转移S-NACH处理的裸鼠模型表现出有效的抗转移功效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号